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Novelty statement  
• Here we examined for the first time, a specific aspect of gait that may lead to an 
increased risk of tripping during walking, and which may contribute to explaining 
the increased fall rate in patients with diabetic peripheral neuropathy.  
• We showed that patients with diabetic peripheral neuropathy are less accurate at 
stepping than control participants, and theorised how this may lead to a 
decreased ability to negotiate around obstacles. 
 
 
 
 
 
 
Aims: Patients with diabetic peripheral neuropathy are five times more likely to fall than 
age-matched controls, however the causes for this have not yet been elucidated. The 
ability to direct the lower limbs where desired is important when negotiating obstacles, 
and has been shown to be related to the risk of falling. This study examines the 
stepping accuracy of people with diabetes and diabetic peripheral neuropathy. 
 
Methods: 14 patients with diabetic peripheral neuropathy (DPN), 12 patients with 
diabetes but no neuropathy (D) and 10 healthy non-diabetic control participants (C) took 
part in the study. Accuracy of stepping was measured whilst the participants walked 
along a walkway consisting of 18 stepping targets. 
 
Results: Patients with diabetes and diabetic peripheral neuropathy were significantly 
less accurate at stepping on targets than control participants. (p<0.05).  
 
Conclusions: Impaired motor control is theorised to be a major factor underlying the 
changes in stepping accuracy and potentially altered visual gaze behaviour may also 
play a role. Reduced stepping accuracy may indicate a decreased ability to control the 
placement of the lower limbs, leading to patients with neuropathy potentially being less 
able to avoid observed obstacles during walking. 
 
 
 
 
Introduction 
 
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes, 
characterised by sensory loss in the lower limbs, altered joint-position sensation and 
impaired muscular function, which can result in alterations to gait [1-3]. Patients with 
neuropathy are five times more likely to fall than age-matched controls, and 
approximately 50% of all falls are due to tripping whilst walking [4,5]. It has been 
suggested that the incidence of trip related falls is determined primarily by the frequency 
of tripping, and not the ability to recover from a trip [6]. Therefore, the most effective 
approach to identifying the risk of falling for a particular individual or population is to 
examine their ability to avoid potential tripping hazards [7,8].  
 
Tripping can occur as a result of observed and unobserved hazards. If a tripping hazard 
is observed, the person must initiate and co-ordinate a response to avoid it. People with 
a high risk of falling have been shown to be less accurate and more variable at stepping 
onto defined targets [9,10]. This reduced ability to move the foot where desired may 
indicate an impaired control of foot trajectory, which could hinder obstacle avoidance, 
and ultimately increase the probability of tripping on observed hazards [7]. Causes for a 
decreased accuracy of stepping are expected to be multi-faceted, with altered motor 
control and visual gaze strategies expected to be contributory factors. Whilst visual 
gaze strategy has not to our knowledge been evaluated in people with diabetes, it is 
known that people with a high risk of falling, such as the elderly population, display 
differing visual gaze strategies to lower risk groups, altering where and when they look 
during walking [9-11]. Previous studies have theorised that visual gaze strategy alters 
stepping accuracy through taking attention away from the combined positions of the feet 
and intended targets, but no universal agreement on the exact mechanisms currently 
exist [9,10]. 
 
The aim of this study was to investigate the effects of diabetic peripheral neuropathy on 
stepping accuracy during level ground walking. Furthermore, this study aimed to provide 
pilot observations of between-group differences in underlying visual gaze strategies, 
which may affect stepping accuracy. It was hypothesised that patients with neuropathy 
would display similar characteristics to other populations at a high risk of falling, 
displaying a decreased accuracy of stepping.  
 
 
 
 
 
 
 
 
 
 
 
 
Patients and methods 
 
Participants 
Thirty six participants: 14 patients with diabetic peripheral neuropathy [DPN], 12 
patients with diabetes but no neuropathy [D] and 10 healthy non-diabetic control 
participants [C] matched for age and BMI (Table 1.) gave their written informed consent 
to participate in this study, which was given ethical approval from the relevant bodies. 
Major exclusion criteria were open ulcers, use of walking aids, a history of other 
disorders affecting gait, and a visual acuity <6/18 (of any aetiology, including diabetic 
retinopathy; identified by performing a Snellen test)[12]. 
 
Neuropathy Assessment 
The presence and severity of neuropathy was measured using two separate tests: the 
modified Neuropathy Disability Score (mNDS)[1], and the Vibration Perception 
Threshold (VPT)[1] using a neurothesiometer (Horwell, Nottingham UK). Patients were 
deemed to have moderate to severe neuropathy and grouped as DPN if in either one or 
both of their feet they displayed either an mNDS score of ≥6, or a VPT of ≥25 Volts (or 
both). Patients were deemed to have no neuropathy and were grouped as D, if in both 
feet they displayed scores for the mNDS of ≤5 and for the VPT of ≤24 Volts (1)(Table 
1.) 
 
 
 
Procedure  
Preparation 
Participants wore tight-fitting clothing (t-shirt and shorts) and therapeutic, open toe 
shoes with a relatively stiff footbed (Darko MedSurg, Raisting, Germany), as issued by 
the research team. Sixteen retro-reflective markers were attached to the participant’s 
feet (8 on each foot) on bony prominences of the metatarsals and toes. Three 
dimensional marker positions were recorded by a ten-camera motion capture system 
recording at 120Hz (Vicon Nexus, Vicon, Oxford, UK). 
 
Stepping accuracy task 
Participants were asked to walk along a 7m long mat with brightly coloured, circular 
stepping targets (75mm in diameter and positioned flush to the ground) (Fig. 1), until 
five trials were captured, of which three were used for analysis. Each participant was 
given the same instructions: “walk at your natural walking speed, stepping on each of 
the targets as accurately as possible.”  Kinematic data of foot position, and analogue 
data of horizontal eye movement were captured from the middle six stepping targets 
(R4, L4, R5, L5, R6, L6) from a total of eighteen (Fig. 1)[13]. Visual gaze direction was 
obtained using a head-mounted eye-tracking scanner (ASL 500 mobile gaze tracking 
system, Bedford, MA, USA) with a sampling frequency of 50Hz, which used corneal and 
pupil reflections to calculate eye in orbit rotation to an accuracy of one degree. 
 
 
 
Data Analysis 
Foot stepping accuracy 
Stepping accuracy was calculated as the difference between the position of the 2nd 
metatarsal head with respect to the calibrated centre of the targets, at foot-ground 
contact. Foot-ground contact was calculated manually as the point at which the trace of 
the vertical position of the foot reached a fixed minimum height (stance phase). The co-
ordinates of the 2nd metatarsal head at foot-ground contact (medio-lateral: x and 
anterior-posterior: y) were subtracted from the co-ordinates of the calibrated target 
positions to calculate the distance of the 2nd metatarsal head from the target. Using the 
square root of the two squared distances (x and y), the hypotenuse of the triangle, the 
absolute distance between the target and the 2nd metatarsal head, was calculated.     
 
Visual acquisition parameters 
Data from twelve participants (C: 4; D: 4; and DPN: 4 [216 saccades analyzed in total: 
18 saccades per participant]) were used for analysis of visual acquisition. Data were 
obtained from a sub-sample of the cohort due to a number of issues including the time-
consuming nature of these measurements precluding assessment in all participants; 
non-spherical corneal shape as the result of surgery in some participants, and 
eyelashes covering the eyes during the tests in other participants. Because of the small 
cohort of participants, the results are presented as preliminary pilot data.  
 
Two points in the horizontal signal of the eye movement trace were identified: the initial 
visual acquisition of the target (start of visual acquisition), and the point at which gaze 
was subsequently directed away from the target (visual acquisition end). These events 
were identified using the second derivative of the eye position signal, i.e. the eye 
acceleration peak at saccade onset. By using the timing of when each individual target 
was visually acquired, and when gaze was subsequently directed away, four separate 
variables were obtained: the time between visual acquisition of the target and foot-target 
contact; the time between the subsequent saccade away from the target with respect to 
foot-target contact; the time spent looking at the target (fixation duration); and the time 
taken to transfer gaze between targets.  
 
Statistics 
Group differences were tested using a one-way analysis of variance (ANOVA) with a 
Bonferroni post-hoc test, and all significances reported with respect to the control group. 
Values are presented as means ± SD; significance was set at p<0.05. The level of 
agreement between stance time during the stepping task and visual gaze cycle time 
was tested using a Pearson’s correlation.  
 
 
 
 
 
 
 
 
Results 
 
Stepping Accuracy (Fig. 2) 
Patients with diabetes (with and without neuropathy; D and DPN groups) were less 
accurate at stepping, and contacted the ground significantly further away from the 
centre of the target than the control participants (C:38±31mm, D:60±37mm, 
DPN:56±36mm; p<0.05; power = 0.85).   
 
Visual Acquisition Parameters (Fig. 3) 
Markedly different stance times were observed in the cohort providing visual gaze data, 
compared to those observed for the larger cohort (Table 1; stance time (b)), which was 
anticipated may impact on the interpretation of visual gaze results presented in absolute 
time. Visual cycle duration correlated very highly with stance time of these participants 
(r = 0.99; Table 1.). Therefore, the results have been presented as a percentage of the 
visual gaze cycle, to elucidate the visual gaze strategy independent of differences in 
stance time. 
 
Patients with neuropathy visually acquired the targets significantly later (C:-87±8%, D:-
78±2%, DPN:-67±10%), and remained looking at the targets until significantly later than 
the control participants (C:0±8%, D:2±8%, DPN:10±13%). The patients with diabetes 
also looked away from targets significantly later than the control participants, but 
visually acquired the target at a similar period before foot-target contact. Both the 
diabetes and diabetic peripheral neuropathy groups spent significantly less time looking 
at the target in total (C:87±2%, D:79±4%, DPN:77±8%), and took significantly longer to 
look between targets (p<0.05) compared to the control participants (C:13±2%, 
D:21±4%, DPN:23±8%) (Fig. 3b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
Patients with diabetes and diabetic peripheral neuropathy (DPN) are less accurate at 
stepping than control participants. This may increase the risk of tripping on observed 
obstacles. Reduced motor control and altered visual gaze strategies are expected to be 
a major contributory factor to the decreased stepping accuracy observed in patients with 
neuropathy. 
  
Patients with neuropathy display a number of functional deficits affecting motor control 
and gait. The reduced speed and coordination at which movements can be performed in 
people with diabetic neuropathy are contributed to by a number of factors: reduced joint 
range of movement, decreased muscle strength, decreased ability to rapidly develop 
strength and a reduced nerve conduction velocity [14-18]. Furthermore, patients with 
neuropathy also display a decreased proprioception, which may impair awareness and 
control of lower limb joint position and orientation during stepping in both normal 
walking, and when negotiating an obstacle [19-21]. 
 
Decreased stepping accuracy in other high fall risk groups has previously been 
explained by altered visual gaze patterns. Yamada et al. identified that the elderly 
patients’ fixation on imminent targets hindered their ability to plan footfall for future 
targets [9], whilst conversely, Chapman & Hollands concluded that the planning of 
future movements affected the accuracy of ongoing movements in elderly adults [10]. In 
the present study we examined visual gaze behaviour in a sub-sample of participants to 
provide insight for its potential contribution towards stepping accuracy. These data, 
however, should be treated with caution due to the small sample size and considered as 
pilot data to be confirmed by future work. These data showed that patients with 
neuropathy displayed a more ‘hesitant’ visual gaze strategy, by continuing to look at 
targets until after foot-target contact, before re-directing gaze to the next target, possibly 
in an attempt to ensure foot-target contact (Fig. 3)[22]. This contrasts with the ‘confident’ 
visual gaze strategy observed in the control participants, who re-directed gaze away to 
the next target immediately upon foot-step contact, indicating a confidence in their 
ability to step accurately. Patients with diabetic neuropathy also displayed an increased 
time interval to look between targets. The combination of looking away from the target 
later, and taking longer to look between targets, may therefore explain why patients with 
neuropathy are slower to initially visually acquire the target, resulting in a decreased 
total time spent looking at the target. Bearing in mind the preliminary nature of these 
visual gaze data, the decreased time available to look at the target during the approach 
may have hindered co-ordination of an appropriate motor response, contributing to 
altered swing trajectories of the lower limbs, and ultimately resulting in a reduced 
stepping accuracy.   
	  
Diabetic controls were slightly less accurate at stepping than patients with diabetic 
neuropathy, and may indicate that diabetic controls displayed some of the altered motor 
control characteristics of patients with neuropathy before sensory neuropathy is 
clinically observed, and before this population are aware of their decreased ability to 
control trajectory of the swinging leg. Bearing in mind the preliminary nature of the 
visual gaze data, the reduced stepping accuracy in diabetic controls may potentially be 
related to a less effective specific aspect of the visual gaze strategy than neuropathy 
patients. This visual gaze strategy in diabetic controls (looking away from the target 
sooner after foot-target contact than patients with neuropathy) could potentially be 
regarded as an ‘over-confident’ strategy that may have adversely affected their stepping 
accuracy, since this was significantly worse than in healthy controls, and even slightly 
less accurate than neuropathy patients. The combination of altered motor control of the 
lower limbs and an ‘over-confident’ visual gaze strategy may potentially explain the poor 
accuracy of stepping in this diabetic control population. However, although differences 
in the visual gaze strategy were clearly evident between groups, these data should be 
treated with caution and considered as preliminary findings due to the small cohorts for 
this parameter. Impaired motor control is expected to be a major factor in reducing 
stepping accuracy in patients with diabetes, and particularly neuropathy, which may 
indicate an impaired ability to avoid any potential upcoming obstacles during walking. 
An altered visual gaze strategy is a potential explanatory factor for the reduced stepping 
accuracy that needs to be confirmed by future research.  
 
Whilst the probability of tripping was not directly measured in this study, these gait 
characteristics may indicate a reduced ability to avoid observed obstacles, posing a 
particular risk to patients with neuropathy. Future studies should therefore look to 
examine the actual ability of patients to avoid obstacles when walking. Previous studies 
in other (non-diabetic) populations have shown that balance can be improved and visual 
gaze strategy can be altered using such training, which could improve safety [13,23]. An 
intervention that aims to modify motor control and visual gaze strategy may improve the 
ability to observe upcoming obstacles and increase the accuracy of stepping, although 
this is also an area for further study. Specifically, a resistance exercise training-based 
element may improve control of the foot and ankle during walking, and improve 
avoidance of any tripping hazards. 
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Figures 
 
Figure 1. Diagram of the stepping walkway used for the stepping accuracy task. Targets 
are numbered in order of contact; with ‘L’ denoting left foot contact (green target) and 
‘R’ denoting right foot contact (red target). 
 
 
Figure 2. Group differences in stepping accuracy for controls (C; n=10), patients with 
diabetes but no neuropathy (D; n=12), and patients with diabetic peripheral neuropathy 
(DPN; n=14). The black inner circle denotes the mean distance from the centre of the 
target (0), and the white outer circle denotes the standard deviation. * denotes 
significantly different group mean accuracy compared to the control group (p<0.05). 
  
 
Figure 3. Target visual acquisition parameters during the stepping task for controls (C; 
n=4), patients with diabetes but no neuropathy (D; n=4), and patients with diabetic 
peripheral neuropathy (DPN; n=4). Values are means and standard deviations. 3a 
displays the results in absolute time and 3b displays the results as a percentage of the 
entire visual gaze cycle. The black bars denote visual fixation of the target, and the 
white bars denote the time looking between targets, with the end of the white bar 
denoting the acquisition of the next target. * denotes significantly different compared to 
control group (p<0.05). 
 
